![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
A study was conducted in mice to teat the efficacy of pulsed electromagnetic fields (PEW) as a means of reducing acute and chronic skin ulceration from two model vesicant anticancer drugs. Adult female BALB/c mice were dehaired dorsally and given 0.5 mg intradermal injections of the DNA intercalators, doxorubicin and bisantrene. The mice-re then housed in plexiglass cages and exposed to 2-Hz PEMF of repetitive pulse bursts of 250 μsec or 20 μsec duration. Skin lesions and survival were assessed daily. There was no significant skin toxicity reduction with either PEMF treatment for doxorubicin (acute ulceration) or bisantrene (chronic ulceration). The inclusion of topical DMSO treatments also did not reduce skin ulceration and appeared to increase doxorubicin lethality. The PEMF treatments appeared to slightly increase some of the vesicant ulcers and doxorubicin lethality.